ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CVRX vs NEPH // EV/EBITDA & P/E VALUATION

CVRx Inc. (NASDAQ) VS. Nephros Inc. (NASDAQ) • 15-METRIC TALLY: CVRX 2 — NEPH 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVRX VS. NEPH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CVRX NEPH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 85.30% 61.90% +23.40 CVRX /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 18.90% -53.90 NEPH /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 26.3x — TIE /valuation <GO>
Free Cash Flow Yield — 4.50% — TIE /fcf-yield <GO>
Operating Margin -60.00% 6.10% -66.10 NEPH /operating-margins <GO>
Net Profit Margin -60.00% 6.40% -66.40 NEPH /net-margins <GO>
Revenue Growth (YoY) 10.40% 32.70% -22.30 NEPH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 NEPH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.9 36.7 -4.80 NEPH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 25.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $38.0M $35.5M $2.4M CVRX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CVRX REV NEPH REV CVRX GROSS % NEPH GROSS % CVRX FCF NEPH FCF
FY 2025 $56.7M $18.8M 85.3% 61.9% -$40.8M $1.6M
FY 2024 $51.3M $14.2M 83.8% 61.6% -$40.5M -$547.0K
FY 2023 $39.3M $14.2M — — -$39.0M $827.0K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVRX // BETA —
NEPH // BETA —